68
Views
13
CrossRef citations to date
0
Altmetric
Original Research

MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells

, , , , , , , , , & show all
Pages 775-785 | Published online: 12 Apr 2018

References

  • FriedmanHSKerbyTCalvertHTemozolomide and treatment of malignant gliomaClin Cancer Res2000672585259710914698
  • BirnbaumTHildebrandtJNueblingGSostakPStraubeAGlioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitroJ Neurooncol20111051576521547397
  • di TomasoESnuderlMKamounWSGlioblastoma recurrence after cediranib therapy in patients: lack of “rebound” revascularization as mode of escapeCancer Res2011711192821199795
  • SmitsMNilssonJMirSEmiR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesisOncotarget20101871072021321380
  • StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
  • AgarwalSSaneROberoiROhlfestJRElmquistWFDelivery of molecularly targeted therapy to malignant glioma, a disease of the whole brainExpert Rev Mol Med201113e1721676290
  • EstellerMGarcia-FoncillasJAndionEInactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsN Engl J Med2000343191350135411070098
  • StuppRGanderMLeyvrazSNewlandsECurrent and future developments in the use of temozolomide for the treatment of brain tumoursLancet Oncol20012955256011905710
  • HegiMEDiserensACGorliaTMGMT gene silencing and benefit from temozolomide in glioblastomaN Engl J Med200535210997100315758010
  • YoshinoAOginoAYachiKGene expression profiling predicts response to temozolomide in malignant gliomasInt J Oncol20103661367137720428759
  • WellerMTabatabaiGKästnerBMGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trialClin Cancer Res20152192057206425655102
  • SrivenugopalKSYuanXHFriedmanHSAli-OsmanFUbiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-ben-zylguanine or 1,3-bis(2-chloroethyl)-1-nitrosoureaBiochemistry1996354132813348573590
  • Esquela-KerscherASlackFJOncomirs: microRNAs with a role in cancerNat Rev Cancer20066425926916557279
  • AkaoYNakagawaYNaoeTMicroRNAs 143 and 145 are possible common onco-microRNAs in human cancersOncol Rep200616484585016969504
  • ChanJAKrichevskyAMKosikKSMicroRNA-21 is an antiapoptotic factor in human glioblastoma cellsCancer Res200565146029603316024602
  • CowlandJBHotherCGrønbaekKMicroRNAs and cancerAPMIS2007115101090110618042145
  • IorioMVFerracinMLiuCGMicroRNA gene expression deregulation in human breast cancerCancer Res200565167065707016103053
  • WuLCaiCWangXLiuMLiXTangHMicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cellsFEBS Lett201158591322133021482222
  • DengBZhangYZhangSWenFMiaoYGuoKMicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7Tumour Biol201536108065807325976503
  • LeiZXuGWangLMiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancerFASEB J20142862696270424558198
  • ChiouGYChienCSWangMLEpigenetic regulation of the miR-142-3p/interleukin-6 circuit in glioblastomaMol Cell201352569370624332177
  • UjifukuKMitsutakeNTakakuraSmiR-195, miR-455-3p and miR-10a* are implicated in acquired temozolomide resistance in glioblastoma multiforme cellsCancer Lett2010296224124820444541
  • PalanichamyJKRaoDSmiRNA dysregulation in cancer: towards a mechanistic understandingFront Genet201455424672539
  • ShresthaAMukhametshinaRTTaghizadehSMicroRNA-142 is a multifaceted regulator in organogenesis, homeostasis, and diseaseDev Dyn2017246428529027884048
  • XiaoPLiuWLMiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinomaInt J Clin Exp Pathol201589108001080726617792
  • ChenYZhouXQiaoJBaoAMiR-142-3p overexpression increases chemo-sensitivity of NSCLC by inhibiting HMGB1-mediated autophagyCell Physiol Biochem20174141370138228427045
  • LiuKHuangJNiJMALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5pCell Cycle201716657858728346809
  • XuGWangJJiaYShenFHanWKangYMiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1Cell Physiol Biochem20143351329133924803022
  • ChenYHuFZhouYChenWShaoHZhangYMGMT promoter methylation and glioblastoma prognosis: a systematic review and meta-analysisArch Med Res201344428129023608672
  • GrimsonAFarhKKJohnstonWKGarrett-EngelePLimLPBartelDPMicroRNA targeting specificity in mammals: determinants beyond seed pairingMol Cell20072719110517612493
  • JacksonALBurchardJSchelterJWidespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarityRNA20061271179118716682560
  • LewisBPBurgeCBBartelDPConserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targetsCell20051201152015652477
  • MathonnetGFabianMRSvitkinYVMicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4FScience200731758451764176717656684
  • ChiSWZangJBMeleADarnellRBArgonaute HITS-CLIP decodes microRNA-mRNA interaction mapsNature2009460725447948619536157
  • SeokHHamJJangESChiSWMicroRNA target recognition: insights from transcriptome-wide non-canonical interactionsMol Cells201639537538127117456
  • FlamandMNGanHHMayyaVKGunsalusKCDuchaineTFA non-canonical site reveals the cooperative mechanisms of microRNA-mediated silencingNucleic Acids Res201745127212722528482037
  • KhalilSFabbriESantangeloAmiRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastomaOncotarget2016719281952820627057640
  • KushwahaDRamakrishnanVNgKA genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomasOncotarget2014124026403924994119
  • AndaTShabaniHKTsunodaKRelationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysisNeurol Res200325324124812739231
  • BrellMTortosaAVergerEPrognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomasClin Cancer Res200511145167517416033832
  • GusyatinerOHegiMEGlioma epigenetics: from subclassification to novel treatment optionsSemin Cancer Biol Epub20171121
  • BlancJLWagerMGuilhotJCorrelation of clinical features and methylation status of MGMT gene promoter in glioblastomasJ Neurooncol200468327528315332332
  • SadonesJMichotteAVeldPMGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastomaEur J Cancer200945114615318945611
  • TaylorJWSchiffDTreatment considerations for MGMT-unmethylated glioblastomaCurr Neurol Neurosci Rep201515150725394859
  • LowSYHoYKTooHPYapCTNgWHMicroRNA as potential modulators in chemoresistant high-grade gliomasJ Clin Neurosci201421339540024411131